0001104659-23-001403.txt : 20230105
0001104659-23-001403.hdr.sgml : 20230105
20230105160609
ACCESSION NUMBER: 0001104659-23-001403
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THANGARAJ IMMANUEL
CENTRAL INDEX KEY: 0001213308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 23511295
MAIL ADDRESS:
STREET 1: 10001 WOODLOCH FOREST DRIVE SUITE 175
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0000786947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 110853640
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
BUSINESS PHONE: 847-705-7709
MAIL ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
STREET 2: .
CITY: PALATINE
STATE: IL
ZIP: 60067
FORMER COMPANY:
FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW
DATE OF NAME CHANGE: 19920703
4
1
tm231734-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-03
0
0000786947
ACURA PHARMACEUTICALS, INC
ACUR
0001213308
THANGARAJ IMMANUEL
335 BRYANT STREET, #3
PALO ALTO
CA
94301
1
0
0
0
Common Stock
2023-01-03
4
M
0
66666
A
397647
D
Common Stock
1956396
I
By Essex Woodlands Health Venture Fund V, L.P.
Restricted Stock Units (2021 Plan)
2023-01-03
4
M
0
66666
D
Common Stock
66666
0
D
Restricted Stock Units (2021 Plan)
2023-01-03
4
A
0
50000
D
Common Stock
50000
50000
D
Represents exchange of restricted stock units.
Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
Does not include Restricted Stock Units.
1 - for - 1
66,666 Restricted Stock Units were granted on January 3, 2022. 25% of Restricted Stock Units vested on the last day of each of March, June, September and December 2022. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
N/A
50,000 Restricted Stock Units were granted on January 3, 2023. 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2023, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2024, or earlier upon a change of control.
The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Immanuel Thangaraj
2023-01-05